ABS Investment ASI SA (WSE:AIN)

Verve Therapeutics Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.19	0.17	0.11	0.07	0.84	2.06
Short-Term Investments	4.48	3.95	6.58	10.08	10.81	17.77
Cash & Short-Term Investments	4.67	4.12	6.69	10.14	11.65	19.82
Cash Growth	-35.43%	-38.43%	-34.06%	-12.92%	-41.23%	36.33%
Accounts Receivable	0.01	-	0.01	0.01	0.01	0.13
Other Receivables	0.3	0.68	0.74	0.73	0.65	1.59
Receivables	0.66	1.03	1.02	0.98	0.66	1.72
Inventory	0.06	0.06	0.06	0.06	0.04	0.26
Other Current Assets	0	0	0	0.01	0	0
Total Current Assets	5.4	5.21	7.77	11.19	12.35	21.81
Long-Term Investments	1.05	1.05	1.1	1.98	3.85	0.17
Long-Term Deferred Tax Assets	0.15	0.08	0.24	0.25	0.23	0.41
Other Long-Term Assets	0.48	0.48	0.48	0.47	0.47	0.81
Total Assets	7.07	6.82	9.59	13.89	16.91	23.2
Accounts Payable	0	0	0	0	0	0.03
Accrued Expenses	0.02	0.02	0.02	0.07	0.05	0.03
Current Portion of Long-Term Debt	-	-	-	0.01	0.7	4.25
Current Income Taxes Payable	0.02	0.02	0.01	0.01	0.02	0.04
Current Unearned Revenue	0.05	0.05	0.05	-	-	-
Other Current Liabilities	0.14	0.14	0.14	0.38	0.47	0.65
Total Current Liabilities	0.23	0.24	0.23	0.48	1.25	4.99
Long-Term Debt	-	-	-	0.7	-	0.2
Long-Term Deferred Tax Liabilities	0	0.22	0	0.73	0.89	1.97
Total Liabilities	0.23	0.46	0.23	1.92	2.13	7.16
Common Stock	8	8	8	8	8	8
Additional Paid-In Capital	12.6	12.6	15.22	15.22	15.22	11.28
Retained Earnings	-18.29	-18.77	-18.4	-15.78	-12.98	-9.24
Comprehensive Income & Other	4.53	4.53	4.53	4.53	4.53	4.53
Total Common Equity	6.84	6.36	9.35	11.98	14.77	14.57
Minority Interest	-	-	-	-	-	1.47
Shareholders' Equity	6.84	6.36	9.35	11.98	14.77	16.04
Total Liabilities & Equity	7.07	6.82	9.59	13.89	16.91	23.2
Total Debt	-	-	-	0.71	0.7	4.45
Net Cash (Debt)	4.67	4.12	6.69	9.43	10.95	15.37
Net Cash Growth	-35.43%	-38.43%	-29.10%	-13.84%	-28.78%	61.74%
Net Cash Per Share	0.61	0.53	0.87	1.22	-	1.99
Filing Date Shares Outstanding	7.72	7.72	7.72	7.73	-	7.73
Total Common Shares Outstanding	7.72	7.72	7.72	7.73	-	7.73
Working Capital	5.16	4.98	7.54	10.71	11.11	16.81
Book Value Per Share	0.89	0.82	1.21	1.55	-	1.89
Tangible Book Value	6.84	6.36	9.35	11.98	14.77	14.57
Tangible Book Value Per Share	0.89	0.82	1.21	1.55	-	1.89
Machinery	-	0.01	0.01	-	-	0.03

Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.